Literature DB >> 33760402

Chemoenzymatic Synthesis and Facile Purification of Gangliosides.

Yuanyuan Bai1, Hai Yu1, Xi Chen1.   

Abstract

Gangliosides are biologically important sialic acid-containing glycolipids found commonly in human and other vertebrates. Isolation of pure gangliosides from cells or tissues is difficult, and chemical synthesis of gangliosides usually involves numerous steps with low synthetic yields. We report here a chemoenzymatic synthesis and purification protocol for two ganglioside cancer antigens, GM3 and GD3. One-pot multienzyme glycosylation reactions are used to sequentially prepare GM3 and GD3 sphingosines from chemically synthesized lactosyl sphingosine. A facile C18-cartridge purification procedure after each glycosylation reaction provides the desired pure glycosyl sphingosine product, which is readily acylated to form the target ganglioside.
© 2021 Wiley Periodicals LLC. Basic Protocol: Chemoenzymatic synthesis and purification of GM3 and GD3 gangliosides Support Protocol: Monitoring reactions by thin-layer chromatography. © 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  carbohydrate; chemoenzymatic synthesis; ganglioside; glycolipid; glycosphingolipid; sialic acid

Mesh:

Substances:

Year:  2021        PMID: 33760402      PMCID: PMC8457310          DOI: 10.1002/cpz1.91

Source DB:  PubMed          Journal:  Curr Protoc        ISSN: 2691-1299


  22 in total

1.  PmST3 from Pasteurella multocida encoded by Pm1174 gene is a monofunctional α2-3-sialyltransferase.

Authors:  Vireak Thon; Yanhong Li; Hai Yu; Kam Lau; Xi Chen
Journal:  Appl Microbiol Biotechnol       Date:  2011-11-11       Impact factor: 4.813

Review 2.  Gangliosides in Nerve Cell Specification.

Authors:  Yutaka Itokazu; Jing Wang; Robert K Yu
Journal:  Prog Mol Biol Transl Sci       Date:  2018-01-17       Impact factor: 3.622

3.  Streamlined chemoenzymatic total synthesis of prioritized ganglioside cancer antigens.

Authors:  Hai Yu; Abhishek Santra; Yanhong Li; John B McArthur; Tamashree Ghosh; Xiaoxiao Yang; Peng G Wang; Xi Chen
Journal:  Org Biomol Chem       Date:  2018-06-06       Impact factor: 3.876

4.  Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.

Authors:  G Ragupathi; M Meyers; S Adluri; L Howard; C Musselli; P O Livingston
Journal:  Int J Cancer       Date:  2000-03-01       Impact factor: 7.396

5.  Chemoenzymatic synthesis of CMP-sialic acid derivatives by a one-pot two-enzyme system: comparison of substrate flexibility of three microbial CMP-sialic acid synthetases.

Authors:  Hai Yu; Hui Yu; Rebekah Karpel; Xi Chen
Journal:  Bioorg Med Chem       Date:  2004-12-15       Impact factor: 3.641

Review 6.  Ganglioside GM3 and Its Role in Cancer.

Authors:  Changping Zheng; Marco Terreni; Matthieu Sollogoub; Yongmin Zhang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

Review 7.  Recent advances in the glycosylation of sphingosines and ceramides.

Authors:  José Antonio Morales-Serna; Omar Boutureira; Yolanda Díaz; M Isabel Matheu; Sergio Castillón
Journal:  Carbohydr Res       Date:  2007-04-11       Impact factor: 2.104

8.  Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.

Authors:  Jiansong Cheng; Hai Yu; Kam Lau; Shengshu Huang; Harshal A Chokhawala; Yanhong Li; Vinod Kumar Tiwari; Xi Chen
Journal:  Glycobiology       Date:  2008-05-28       Impact factor: 4.313

Review 9.  Gangliosides in Cancer Cell Signaling.

Authors:  Sophie Groux-Degroote; Macarena Rodríguez-Walker; Justine H Dewald; Jose L Daniotti; Philippe Delannoy
Journal:  Prog Mol Biol Transl Sci       Date:  2018-01-19       Impact factor: 3.622

Review 10.  Gangliosides: Treatment Avenues in Neurodegenerative Disease.

Authors:  Pierre J Magistretti; Fred H Geisler; Jay S Schneider; P Andy Li; Hubert Fiumelli; Simonetta Sipione
Journal:  Front Neurol       Date:  2019-08-06       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.